MTOR and neoplasm: This fact corroborates the compromised function of the placenta, as a study conducted in MAC16 tumour-bearing mice showed that the presence of the tumour during pregnancy negatively regulated the MAPK/ERK and PI3K/Akt/mTOR signalling pathways, resulting in a decrease in foetal growth and a decrease in placental cell activity [6].